Señales en vivo de 300298.SZ | Maximiza tus Ganancias con Getagraph.com

Live Chart Being Loaded With Signals

Commentary (7 may 2024 @ 03:04):

Sinocare Inc. engages in the development, manufacture, and marketing of diagnosis rapid testing products primarily in the People's Republic of China...

Stats
Volumen de hoy	4.40M
Volumen promedio	5.10M
Capitalización de mercado	13.62B
EPS	CNY0.256 ( 2023-10-23 )
Próxima fecha de ganancias	( CNY0 ) 2024-05-21
Last Dividend	CNY0 ( N/A )
Next Dividend	CNY0 ( N/A )
P/E	44.71
ATR14	CNY0.0350 (0.14%)

Volumen Correlación

Largo: 0.12 (neutral)

Corto: 0.25 (neutral)

Signal:(56.049) Neutral

Sinocare Inc. Correlación

10 Correlaciones Más Positivas

10 Correlaciones Más Negativas

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Sinocare Inc. Correlación - Moneda/Commodity

-0.36
( neutral )

0.06
( neutral )

0.00
( neutral )

0.40
( neutral )

-0.53
( weak negative )

0.09
( neutral )

Sinocare Inc. Finanzas

Annual	2023
Ingresos:	CNY4.06B
Beneficio Bruto:	CNY2.19B (54.06 %)
EPS:	CNY0.510

FY	2023
Ingresos:	CNY4.06B
Beneficio Bruto:	CNY2.19B (54.06 %)
EPS:	CNY0.510

FY	2022
Ingresos:	CNY2.81B
Beneficio Bruto:	CNY1.65B (58.71 %)
EPS:	CNY0.770

FY	2021
Ingresos:	CNY2.36B
Beneficio Bruto:	CNY1.42B (59.97 %)
EPS:	CNY0.192

Financial Reports:

No articles found.

Sinocare Inc.

Sinocare Inc. engages in the development, manufacture, and marketing of diagnosis rapid testing products primarily in the People's Republic of China. It offers SARS-CoV-2 antibody test strip; Safe-Accu blood glucose monitoring systems; Safe-AQ blood glucose monitoring systems; Gold-Accu blood glucose monitoring systems; Safe-Accu UG blood, glucose, and uric acid monitoring systems; Safe-Accu KG blood, glucose, and ketone monitoring systems; and D Nurse mobile glucose meters. The company provides its products for the patients with chronic diseases and diabetes, as well as for healthcare professionals. It also exports its products to 135 countries. Sinocare Inc. was founded in 2002 and is based in Changsha, the People's Republic of China.